EUVIMEDEUVIMED entdecken
Crossref

Serum Mycophenolic Acid Levels and Infection Risk in Myasthenia Gravis

Gyeong Mo Sohn iD, Kyong Jin Shin iD

Muscle & Nerve · 2026-12 · 74 (6) · 1636-1643

DOI: 10.1002/mus.70428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 20.10.2026. Verfasst von Gyeong Mo Sohn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Haeundae-Paik Hospital, Inje University, Busan, South Korea. Hauptthemen laut MEDLINE: Myasthenia Gravis, Mycophenolic Acid, Immunosuppressive Agents, Infections. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Evidence linking serum mycophenolic acid (MPA) concentrations with safety outcomes in myasthenia gravis (MG) is limited. We evaluated whether single serum MPA concentrations were associated with clinically documented infection.

Methods

This retrospective study included acetylcholine receptor antibody‐positive MG patients treated with mycophenolate mofetil (MMF) for at least 1 year who had MPA and mycophenolic acid glucuronide (MPAG) measurement with same‐day complete blood count testing. Exact sampling time relative to MMF dosing was not uniformly documented; therefore, values were analyzed as single serum concentrations rather than confirmed trough levels.

Results

Among 112 MMF‐treated patients, 60 had MPA/MPAG measurement, and 10 had recent infection. Serum MPA concentration correlated strongly and positively with MPAG concentration ( r = 0.717) and moderately and inversely with lymphocyte count ( r = −0.406). Infection occurred in 0/18 low, 2/24 intermediate, and 8/18 high MPA concentration groups. Patients with infection had higher MPA concentration (median 6.15 vs. 1.80 μg/mL; Bonferroni‐adjusted p = 0.032) and higher MPA concentration per prescribed MMF dose.

Discussion

Higher single serum MPA concentrations were associated with recent infection. Prospective controlled studies including patients not treated with MMF are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisMycophenolic AcidImmunosuppressive AgentsInfectionsHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedGlucuronides

Stichwörter der Autor:innen

infectionmyasthenia gravismycophenolate mofetilmycophenolic acidserum concentration

Substanzen

Mycophenolic AcidImmunosuppressive Agentsmycophenolic acid glucuronideGlucuronides

Autor:innen und Institutionen

  • Department of Neurology, Haeundae-Paik Hospital, Inje University, Busan, South Korea.

ORCID-Profile: Gyeong Mo Sohn, Kyong Jin Shin

Zitieren

APA

Sohn, G. M., & Shin, K. J. (2026). Serum Mycophenolic Acid Levels and Infection Risk in Myasthenia Gravis. Muscle & Nerve, 74(6), 1636-1643. https://doi.org/10.1002/mus.70428

Vancouver

Sohn GM, Shin KJ. Serum Mycophenolic Acid Levels and Infection Risk in Myasthenia Gravis. Muscle & Nerve. 2026;74(6):1636-1643. doi:10.1002/mus.70428

BibTeX
@article{Sohn2026,
  author = {Sohn, Gyeong Mo and Shin, Kyong Jin},
  title = {Serum Mycophenolic Acid Levels and Infection Risk in Myasthenia Gravis},
  journal = {Muscle & Nerve},
  year = {2026},
  volume = {74},
  number = {6},
  pages = {1636--1643},
  doi = {10.1002/mus.70428}
}
Kostenlos starten →